Status:
COMPLETED
Comprehensive Approach to Hypertension Management in Nepal
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
Institute for Implementation Sciences and Health, Kathmandu, Nepal
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hypertension is a global risk factor for cardiovascular diseases. Approximately 80% hypertension burden is in low-and-middle income countries. Hypertension can be managed with antihypertensive medicat...
Eligibility Criteria
Inclusion
- Hypertension patients (systolic blood pressure 140 mmHg or more and/or diastolic blood pressure 90 mmHg or more on at least two separate visits, or use of antihypertensive medication)
- Living in the area served by the participating health facilities
Exclusion
- Pregnancy
- Not able or willing to give informed consent,
- Critically ill from depilating conditions such as dialysis, cancer, palliative care
- Not likely to continue living in the area served by the health facility during trial follow up period (8 months)
Key Trial Info
Start Date :
May 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 29 2023
Estimated Enrollment :
1252 Patients enrolled
Trial Details
Trial ID
NCT05292469
Start Date
May 2 2022
End Date
August 29 2023
Last Update
June 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Implementation Sciences and Health
Kathmandu, Nepal